Skip to content

BioLife Solutions BLFS Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Azenta logo
AzentaAZTA
Baxter International logo
Baxter InternationalBAX
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Charles River Laboratories logo
Charles River LaboratoriesCRL
Labcorp Holdings logo
Labcorp HoldingsLH
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's finite-lived intangible assets, accumulated amortization?
BioLife Solutions (BLFS) reported finite-lived intangible assets, accumulated amortization of $6.68M in Q1 2026.
How has BioLife Solutions's finite-lived intangible assets, accumulated amortization changed year-over-year?
BioLife Solutions's finite-lived intangible assets, accumulated amortization decreased by 59.6% year-over-year, from $16.54M to $6.68M.
What is the long-term trend for BioLife Solutions's finite-lived intangible assets, accumulated amortization?
Over 3 years (2022 to 2025), BioLife Solutions's finite-lived intangible assets, accumulated amortization has grown at a -23.7% compound annual growth rate (CAGR), from $14.29M to $6.36M.